Compugen
CGEN • NASDAQ
Compugen is a biotechnology company in the healthcare sector trading on NASDAQ, led by CEO Eran Ophir, with a market cap of $192.9M.
CEOEran Ophir
Next Earnings
Upcoming earnings announcement for Compugen
Date
Monday, May 18, 2026 (in 2 months)
Timing
Before Market Open (7:00 AM New York)
Fiscal Period
Q1 2026
EPS Estimate
-$0.08
Revenue Estimate
$1.8M
Earnings History
Past 12 earnings reports for Compugen
| Date | Period | EPS | EPS Surprise | Revenue | Rev. Surprise | Filing |
|---|---|---|---|---|---|---|
| Mar 2, 2026 | Q4 2025 | $0.60Est: $0.10 | +500.0% | $67.3MEst: $15.7M | +328.2% | — |
| Nov 10, 2025 | Q3 2025 | -$0.07Est: -$0.09 | +22.2% | $1.9MEst: $2.7M | -29.2% | — |
| Aug 6, 2025 | Q2 2025 | -$0.08Est: -$0.08 | 0.0% | $1.3MEst: $4.5M | -71.9% | — |
| May 19, 2025 | Q1 2025 | -$0.08Est: -$0.05 | -60.0% | $2.3MEst: $3.7M | -38.3% | — |
| Mar 4, 2025 | Q4 2024 | -$0.07Est: $0.07 | -200.0% | $1.5MEst: $17.5M | -91.6% | — |
| Nov 12, 2024 | Q3 2024 | $0.01Est: $0.10 | -90.0% | $17.1MEst: $17.9M | -4.1% | — |
| Aug 6, 2024 | Q2 2024 | -$0.02Est: -$0.07 | +71.4% | $6.7MEst: $2.5M | +169.2% | — |
| May 20, 2024 | Q1 2024 | -$0.08Est: -$0.02 | -300.0% | $2.6MEst: $6.2M | -58.8% | — |
| Mar 5, 2024 | Q4 2023 | $0.11Est: $0.23 | -52.2% | $33.5MEst: $20.0M | +67.3% | — |
| Nov 7, 2023 | Q3 2023 | -$0.11Est: -$0.09 | -22.2% | -Est: $2.5M | -100.0% | — |
| Aug 7, 2023 | Q2 2023 | -$0.11Est: -$0.13 | +15.4% | - | — | — |
| May 15, 2023 | Q1 2023 | -$0.11Est: -$0.12 | +8.3% | - | — | — |